Merck (MRK)
Merck R&D Expense: 1.862B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MRK R&D Expense Rankings
| Overall | 0th percentile | 1758 of 1763 |
| Sector | 0th percentile | 411 of 413 in Healthcare |
| Industry | 7th percentile | 23 of 25 in Drug Manufacturers - Major |
MRK R&D Expense Range, Past 5 Years
| Minimum | 1.030B | Jun 2007 |
| Maximum | 4.559B | Dec 2010 |
| Average | 1.797B |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these MRK related companies
MRK News
Still a Bear Market http://stks.co/41w8 $KFT $MCD $MRK $MSFT $PFE $KO
about 8 hours ago by LouisEbner
about 8 hours ago by LouisEbner
Merck to Present at Sanford C. Bernstein 28th Strategic Decisions Conference
May 30, 8:00AM Business Wire
May 30, 8:00AM Business Wire
Perception, Opportunity in Volatility - Research & Analysis on Syntel, Inc. and Merck & Co., Inc.
May 29, 9:00AM Marketwire
May 29, 9:00AM Marketwire
Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids
May 25, 2:01PM Street Insider
May 25, 2:01PM Street Insider
RT @ScottAdams_Edit Best US dividend stocks with growing cash flow http://stks.co/3yVy $PBI $EEP $NNN $PBCT $PAA $AEP $VVC $MRK $UVV $PAYX
about 6 days ago by eyeonequities
about 6 days ago by eyeonequities
Next week should see surge in biotechs ahead of ASCO presentations 1st week in June. $PFE, $MRK, $VVUS
about 6 days ago by EPS_MomentuM
about 6 days ago by EPS_MomentuM
Merck & Co., Inc. (MRK) Declares $0.42 Quarterly Dividend; 4.5% Yield
May 22, 12:57PM Street Insider
May 22, 12:57PM Street Insider
U.S. Suggests All Baby Boomers Should Get Tested for Hepatitis C
May 18, 4:24PM The Wall Street Journal
May 18, 4:24PM The Wall Street Journal
Go into Pharma to avoid the bloodbath in the markets. Rotation into safety $PFE $MRK $JNJ http://stks.co/3tbu
about 12 days ago by EPS_MomentuM
about 12 days ago by EPS_MomentuM
$GALE is Surging for a big Reason, find out why? http://stks.co/3sfo $PFE $MRK $VRTX
about 13 days ago by EPS_MomentuM
about 13 days ago by EPS_MomentuM
@MarketsCJR It worked with $MRK, at least. I've bought $MRK shares when they announced a 10000 job cut, around $31 and they've only gone up.
about 13 days ago by mitrado
about 13 days ago by mitrado
Expectations Indicator triggered a Bear Market http://stks.co/3sK7 $MRK $MSFT $PFE $KO
about 13 days ago by LouisEbner
about 13 days ago by LouisEbner
Merck to Present at Bank of America Merrill Lynch 2012 Healthcare Conference
May 16, 8:00AM Business Wire
May 16, 8:00AM Business Wire
$MRK http://stks.co/3ptm Technical Analysis Merck & Co. $MRK Short target 36.03 (fib 38.2%) Chat: http://stks.co/3ptn
about 15 days ago by SergeymPopov
about 15 days ago by SergeymPopov
$MRK Insider Sale: $1.1M of stock sold by Bowles Richard S Iii on May 10, 2012 http://stks.co/3m0L
about 20 days ago by MarketBrief
about 20 days ago by MarketBrief
Listen to $MRK Merck & Co., Inc. at Deutsche Bank AG Health Care Conference - live at 08:00 AM, ondemand after - http://stks.co/3jpD
about 21 days ago by earningscast
about 21 days ago by earningscast
Holding $MRK and $FE. In cash 80% Sold $V and $SSO yesterday into the close.
about 22 days ago by vjtweet
about 22 days ago by vjtweet
New $DJIA Value Ranks http://stks.co/3gdj like #DogsOfTheDow 1) $HPQ 2) $MSFT 3) $INTC 4) $CVX 5) $AA 6) $JPM 7) $MRK 8 $GE 9 $CSCO 10 $WMT
about 25 days ago by InvestorsGuru
about 25 days ago by InvestorsGuru
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MRK | 37.41 | -0.18 | -0.48% | 114.42B |
| MRH | 20.44 | -0.10 | -0.49% | 1.219B |
| MRGE | 2.40 | -0.08 | -3.23% | 225.70M |
| MRF | 7.84 | -0.06 | -0.76% | |
| MNDO | 1.68 | -0.03 | -1.75% | 32.03M |
| MMYT | 13.61 | -0.64 | -4.49% | 525.11M |
| MMV | 15.00 | +0.00 | +0.03% | |
| MMT | 6.91 | -0.07 | -1.00% | |
| MMSI | 12.98 | -0.23 | -1.74% | 554.82M |
| MMS | 45.86 | -0.57 | -1.23% | 1.567B |
